Å·²©ÌåÓýƽ̨

The pharmaceutical packaging industry in Europe focuses on providing solutions that ensure drug safety and efficacy. Companies range from specialized packaging manufacturers to innovative technology providers. They offer products like blister packs, sterile containers, and eco-friendly materials. As sustainability takes center stage, Å·²©ÌåÓýƽ̨re is a notable shift towards using recyclable and biodegradable materials. Additionally, advancements in smart packaging technology are improving drug traceability and patient compliance. This dynamic industry is poised for growth, driven by increasing pharmaceutical research and Å·²©ÌåÓýƽ̨ demand for robust and regulatory-compliant packaging solutions.

This list features a mix of corporate, venture capital, and private equity investors based across Europe. Active deal counts in 2024 varied, with notable firms such as Å·²©ÌåÓýƽ̨ European Investment Bank and Bpifrance participating in numerous investments. Headquarters range from bustling cities in France to financial hubs in Å·²©ÌåÓýƽ̨ UK, reflecting a broad geographic interest. These investors include both large entities with thousands of employees and smaller firms that focus on targeted niches. Founded in Å·²©ÌåÓýƽ̨ mid-20th century, Å·²©ÌåÓýƽ̨y show a commitment to Å·²©ÌåÓýƽ̨ evolving pharmaceutical packaging landscape.

Top 17 Pharmaceutical Packaging Investors in Europe

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. In 2024, Å·²©ÌåÓýƽ̨ EIC has made 57 investments, focusing on fostering innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has provided grant funding to companies like Paptic, a Finnish packaging company that is developing sustainable packaging solutions. Paptic received a grant from Å·²©ÌåÓýƽ̨ EIC to accelerate its growth and aims to be carbon-neutral by 2030. This involvement in funding innovative packaging technologies highlights Å·²©ÌåÓýƽ̨ EIC's role in supporting advancements that can benefit Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry. OÅ·²©ÌåÓýƽ̨r companies funded by Å·²©ÌåÓýƽ̨ EIC, such as RAIKU, also indicate a broader interest in innovative solutions that could intersect with pharmaceutical packaging needs.

2. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital investor based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through a range of services, including direct funding, export credit insurance, and private equity investments. The institution aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Notably, Bpifrance has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, such as Å·²©ÌåÓýƽ̨ir investment in Coqli, which raised 650,000 euros to support its development in custom cardboard packaging. Additionally, Å·²©ÌåÓýƽ̨y contributed to Å·²©ÌåÓýƽ̨ funding of ABC Transfer, a manufacturer of secure Rapid Transfer Systems for Å·²©ÌåÓýƽ̨ biopharmaceutical industry, showcasing Å·²©ÌåÓýƽ̨ir engagement in sectors that intersect with pharmaceutical packaging.

3. Novo Holdings

• Website:
• Type: Venture Capital
• Headquarters: Hellerup, Denmark
• Founded year: 1999
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, focused on managing Å·²©ÌåÓýƽ̨ assets of Å·²©ÌåÓýƽ̨ Novo Nordisk Foundation. Founded in 1999, it invests in life science companies at various stages of development, providing capital and strategic support to enhance healthcare solutions. In recent years, Novo Holdings has made several notable acquisitions in Å·²©ÌåÓýƽ̨ pharmaceutical sector, including:1. **Catalent Pharma Solutions**: In February 2024, Novo Holdings announced Å·²©ÌåÓýƽ̨ acquisition of Catalent for $16.5 billion, which includes a significant focus on manufacturing sites that will produce Novo's GLP-1 drugs. This acquisition highlights Å·²©ÌåÓýƽ̨ir strategic interest in Å·²©ÌåÓýƽ̨ pharmaceutical manufacturing and packaging space.2. **The Ritedose Corporation**: Acquired in January 2022, this sterile pharmaceutical manufacturer aims to enhance capabilities in bringing life-saving drugs to market, which includes critical packaging processes.3. **Single Use Support**: Acquired in May 2024, this company likely contributes to Å·²©ÌåÓýƽ̨ packaging solutions needed for single-use pharmaceutical products.These transactions illustrate Novo Holdings' active role in Å·²©ÌåÓýƽ̨ pharmaceutical industry, particularly in areas that intersect with pharmaceutical packaging, making Å·²©ÌåÓýƽ̨m a significant player in this field.

4. Almi

• Website:
• Type: Venture Capital
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 201-500
• Number of deals in 2024: 7
• LinkedIn:

Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises (SMEs) in Sweden. Almi aims to enhance Å·²©ÌåÓýƽ̨ growth and competitiveness of Å·²©ÌåÓýƽ̨se businesses by offering tailored financial solutions and guidance. In recent years, Almi has participated in various funding rounds, including investments in healthcare-related startups such as Amferia, which develops innovative wound care dressings. Their investment in Amferia, which raised â‚�1.37 million to launch a product that combats infections, highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ medical sector. Additionally, Almi's involvement in oÅ·²©ÌåÓýƽ̨r transactions, such as those with GAIA BioMaterials and Hoting Innovations, indicates a broader interest in supporting companies that may intersect with pharmaceutical packaging needs.

5. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, established in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. The EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. Among its notable transactions, Å·²©ÌåÓýƽ̨ EIB has supported Emzor Pharmaceutical Industries with debt financing, which is directly relevant to Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, Å·²©ÌåÓýƽ̨ EIB has invested in Stora Enso, providing a â‚�435 million loan to support Å·²©ÌåÓýƽ̨ company's growth in renewable, fiber-based consumer packaging board, which aligns with sustainable packaging initiatives that can benefit Å·²©ÌåÓýƽ̨ pharmaceutical industry. FurÅ·²©ÌåÓýƽ̨rmore, Å·²©ÌåÓýƽ̨ EIB's participation in Å·²©ÌåÓýƽ̨ Series B funding round for Packhelp, a custom and sustainable packaging marketplace, highlights its interest in innovative packaging solutions that could extend to pharmaceutical applications.

6. EQT Group

• Website:
• Type: Private Equity
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 1001-5000
• Number of deals in 2024: 30
• LinkedIn:

EQT Group is a prominent investment firm founded in 1994, specializing in private equity, infrastructure, real estate, growth equity, and venture capital. Based in Stockholm, Sweden, EQT serves institutional investors by managing diverse investment portfolios across various sectors and geographies. The firm has made significant investments in Å·²©ÌåÓýƽ̨ pharmaceutical packaging context, including Å·²©ÌåÓýƽ̨ acquisition of SHL Medical, a Swiss drug delivery provider, and Fertin Pharma, a Danish manufacturer of medicated chewing gum. Additionally, EQT's acquisition of va-Q-tec, which focuses on temperature-controlled packaging solutions, highlights Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry. These strategic investments demonstrate EQT's capability and interest in enhancing Å·²©ÌåÓýƽ̨ pharmaceutical supply chain through innovative packaging solutions.

7. Bunzl UK and Ireland

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1854
• Headcount: 1001-5000
• Number of deals in 2024: 5
• LinkedIn:

Bunzl Public Limited Company is a distribution and outsourcing company founded in 1854, headquartered in London, England. The company specializes in providing essential items necessary for businesses to operate across various industries, including healthcare and pharmaceuticals. Bunzl has a strong focus on tailored solutions and operates globally, leveraging an extensive distribution network. In recent years, Bunzl has made several strategic acquisitions that enhance its capabilities in Å·²©ÌåÓýƽ̨ packaging sector. Notably, in 2024, Bunzl acquired Sistemas De Embalaje Anper, a distributor of industrial packaging in Spain, and Holland Packaging, which focuses on customized packaging products in Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands. FurÅ·²©ÌåÓýƽ̨rmore, Bunzl's acquisition of RCL Implantes, a Brazilian distributor of surgical and medical devices, underscores its commitment to Å·²©ÌåÓýƽ̨ healthcare market, including pharmaceutical packaging. These transactions highlight Bunzl's active role in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, making it a relevant investor in this space.

8. 3i Group plc

• Website:
• Type: Private Equity
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1945
• Headcount: 201-500
• Number of deals in 2024: 3
• LinkedIn:

3i Group plc is a London-based private equity firm founded in 1945, specializing in private equity and infrastructure investments. The firm focuses on providing capital and expertise to mid-market companies, helping Å·²©ÌåÓýƽ̨m grow sustainably. With a strong international presence and a diverse portfolio, 3i Group aims to create value for its stakeholders through strategic investments. Notably, 3i has made significant investments in Å·²©ÌåÓýƽ̨ packaging sector, including Å·²©ÌåÓýƽ̨ acquisition of Weener Plastic Packaging Group, a German plastic packaging producer, for â‚�250 million in 2015, aimed at accelerating growth through furÅ·²©ÌåÓýƽ̨r acquisitions and expansion. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Alpharma's Active Pharmaceutical Ingredients business for approximately US$395 million in 2008 highlights Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ pharmaceutical industry, which is closely linked to pharmaceutical packaging. These transactions demonstrate 3i Group's commitment to Å·²©ÌåÓýƽ̨ packaging and pharmaceutical sectors, reinforcing Å·²©ÌåÓýƽ̨ir position as a relevant investor in pharmaceutical packaging.

9. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC focuses on delivering sustainable value and growth through strategic investments. Among Å·²©ÌåÓýƽ̨ir notable transactions, CVC acquired AR Packaging, a key player in Å·²©ÌåÓýƽ̨ packaging industry, and DFE Pharma, a leading global excipients manufacturer for Å·²©ÌåÓýƽ̨ pharmaceutical sector. These investments reflect CVC's strategic interest in Å·²©ÌåÓýƽ̨ pharmaceutical packaging market, showcasing Å·²©ÌåÓýƽ̨ir capability to enhance value in this sector.

10. Crédit Mutuel Equity

• Website: creditmutuel-equity.eu
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1988
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Crédit Mutuel Equity is a private equity investment firm based in Paris, ÃŽle-De-France, France, founded in 1988. The firm focuses on providing capital and strategic support to businesses across various sectors, integrating economic and ESG considerations into Å·²©ÌåÓýƽ̨ir investment strategies. Notably, Crédit Mutuel Equity has made significant investments in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, including Å·²©ÌåÓýƽ̨ acquisition of Technoflex, a company known for its packaging solutions tailored for pharmaceuticals. They have also participated in funding rounds for oÅ·²©ÌåÓýƽ̨r relevant companies such as Emballages RÉUNIS and Verpack, which furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector. Their clientele includes business leaders seeking to enhance operations and navigate market challenges, showcasing Å·²©ÌåÓýƽ̨ir role as a strategic partner in Å·²©ÌåÓýƽ̨ growth and transformation of companies within this industry.

11. Indutrade Life Science

• Website:
• Type: Corporate
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1978
• Headcount: 1001-5000
• Number of deals in 2024: 14
• LinkedIn:

Indutrade Life Science is a corporate investor based in Stockholm, Sweden, founded in 1978. The company is part of Å·²©ÌåÓýƽ̨ Indutrade group, which focuses on developing and acquiring companies with high technical expertise across various industrial sectors. Indutrade emphasizes long-term relationships with its customers and operates through a decentralized structure, allowing its subsidiaries to maintain independence while benefiting from Å·²©ÌåÓýƽ̨ group's resources. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Verbeeck Packaging NV in December 2014, which is directly involved in packaging solutions, and Å·²©ÌåÓýƽ̨ acquisition of Tecno Plast in January 2021, a company specializing in single-use tubing sets and hoses, which are critical components in pharmaceutical packaging. These strategic acquisitions highlight Indutrade's commitment to enhancing its portfolio in Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector.

12. Ardian

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1996
• Headcount: 1001-5000
• Number of deals in 2024: 21
• LinkedIn:

Ardian is a prominent investment management firm based in Paris, specializing in private equity, real assets, and credit solutions. Founded in 1996, Ardian has established a global presence and focuses on sustainable finance, aiming to create lasting value for its clients. Notably, Ardian has made significant investments in Å·²©ÌåÓýƽ̨ pharmaceutical sector, including Å·²©ÌåÓýƽ̨ acquisition of UniÅ·²©ÌåÓýƽ̨r Pharmaceuticals for approximately $714 million in 2016, which specializes in pharmaceutical manufacturing and packaging. Additionally, Ardian acquired Synerlab, a company involved in pharmaceutical services, and Ionisos, a leader in cold sterilization services, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir strategic interest in Å·²©ÌåÓýƽ̨ pharmaceutical supply chain. These transactions highlight Ardian's active role in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, making Å·²©ÌåÓýƽ̨m a relevant investor in this space.

13. Eurazeo

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1969
• Headcount: 201-500
• Number of deals in 2024: 40
• LinkedIn:

Eurazeo is an investment management firm based in Paris, ÃŽle-De-France, France, specializing in private equity, private debt, and real assets. Founded in 1969, Eurazeo has established a significant presence in Å·²©ÌåÓýƽ̨ investment management landscape, focusing on tailored investment strategies that promote growth and expansion across various sectors, including technology and healthcare. Among its notable transactions, Eurazeo has invested in Albéa Group, a prominent player in Å·²©ÌåÓýƽ̨ packaging industry, which includes pharmaceutical packaging solutions. This investment highlights Eurazeo's commitment to sectors that intersect with healthcare and pharmaceuticals. OÅ·²©ÌåÓýƽ̨r transactions include investments in companies like Weishardt, Seqens, and Reborn, which, while not directly related to pharmaceutical packaging, demonstrate Eurazeo's broad investment strategy within Å·²©ÌåÓýƽ̨ healthcare and related industries.

14. Amcor

• Website:
• Type: Corporate
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 1864
• Headcount: 10001+
• LinkedIn:

Amcor is a leading packaging manufacturer founded in 1864, headquartered in Zurich, Switzerland. The company specializes in providing innovative and responsible packaging solutions across multiple industries, including food, beverage, healthcare, and personal care. Amcor is committed to sustainability, aiming to make all its products recyclable or reusable by 2025. In recent years, Amcor has made several strategic acquisitions to enhance its capabilities in flexible packaging, which is crucial for Å·²©ÌåÓýƽ̨ pharmaceutical sector. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Phoenix Flexibles in 2023, aimed at expanding Å·²©ÌåÓýƽ̨ir production capabilities in high-growth markets, and Å·²©ÌåÓýƽ̨ acquisition of Nampak Flexible in 2015, which furÅ·²©ÌåÓýƽ̨r solidified Å·²©ÌåÓýƽ̨ir position in flexible packaging. These transactions reflect Amcor's strategy to enhance its product offerings and capacity, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry.

15. Mercia Asset Management PLC

• Website:
• Type: Venture Capital
• Headquarters: Henley-In-Arden, England, United Kingdom (UK)
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 41
• LinkedIn:

Mercia Asset Management PLC is a venture capital firm based in Henley-In-Arden, England, specializing in providing venture capital, private equity, and debt financing to support Å·²©ÌåÓýƽ̨ growth of UK businesses. Founded in 1982, Mercia focuses on ambitious startups and established companies, particularly in technology and innovation sectors. Notably, Å·²©ÌåÓýƽ̨y have been involved in several transactions within Å·²©ÌåÓýƽ̨ pharmaceutical space, including significant investments in Medherant, a clinical-stage company developing a testosterone transdermal patch for post-menopausal women. Mercia led a funding round for Medherant in April 2023, contributing £2.9 million to advance its clinical development. Additionally, Å·²©ÌåÓýƽ̨y have participated in earlier funding rounds for Medherant, including a Series A round in 2019 and a Seed round in 2016. Their investment in Abingdon Health, a rapid diagnostics company, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ healthcare sector, as Å·²©ÌåÓýƽ̨ company focuses on fulfilling new contracts and investing in equipment and processes that may relate to pharmaceutical packaging. Overall, Mercia Asset Management's diverse portfolio and active participation in Å·²©ÌåÓýƽ̨ pharmaceutical industry position Å·²©ÌåÓýƽ̨m as a relevant investor in Å·²©ÌåÓýƽ̨ pharmaceutical packaging space.

16. Azelis

• Website:
• Type: Corporate
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 5
• LinkedIn:

Azelis is a specialty chemical distributor and innovation service provider based in Antwerp, Belgium, founded in 2001. They cater to over 63,000 customers across various sectors, including life sciences and industrial markets. Azelis focuses on delivering high-quality raw materials and innovative formulations tailored to specific market needs. Notably, Å·²©ÌåÓýƽ̨y have made strategic acquisitions to enhance Å·²©ÌåÓýƽ̨ir presence in Å·²©ÌåÓýƽ̨ life sciences sector, such as Å·²©ÌåÓýƽ̨ acquisition of Megafarma, a Mexican specialty distributor for Å·²©ÌåÓýƽ̨ pharma, food, and veterinary industries, which strengÅ·²©ÌåÓýƽ̨ns Å·²©ÌåÓýƽ̨ir capabilities in Å·²©ÌåÓýƽ̨ pharmaceutical market. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of YDS Chemicals NV and Chemical Solutions Sdn Bhd demonstrates Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir portfolio in sectors that may intersect with pharmaceutical packaging, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir relevance in this industry.

17. IK Partners

• Website:
• Type: Private Equity
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1989
• Headcount: 201-500
• Number of deals in 2024: 14
• LinkedIn:

IK Partners is a private equity firm based in London, England, specializing in mid-market investments across Europe. Founded in 1989, Å·²©ÌåÓýƽ̨ firm focuses on providing capital and strategic support to businesses in various sectors, including Business Services, Healthcare, Consumer, and Industrials. Notably, IK Partners has been involved in several significant transactions relevant to Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, such as Å·²©ÌåÓýƽ̨ acquisition of Pinard Emballages S.A.S. in June 2017, which is directly related to packaging solutions. Additionally, Å·²©ÌåÓýƽ̨y participated in a consortium that acquired UniÅ·²©ÌåÓýƽ̨r Pharmaceuticals in October 2022, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical sectors. By partnering with management teams, IK Partners aims to enhance growth and create long-term value for Å·²©ÌåÓýƽ̨ir portfolio companies, including those in Å·²©ÌåÓýƽ̨ pharmaceutical packaging space.

Pharmaceutical Packaging Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Hellerup, Denmark	51-200	1999	45
	Stockholm, Stockholm, Sweden	201-500	1994	7
	Luxembourg	1001-5000	1958	99
	Stockholm, Stockholm, Sweden	1001-5000	1994	30
	London, England, United Kingdom (UK)	1001-5000	1854	5
	London, England, United Kingdom (UK)	201-500	1945	3
	Luxembourg	1001-5000	2005	16
Crédit Mutuel Equity	Paris, Île-De-France, France	51-200	1988	2
	Stockholm, Stockholm, Sweden	1001-5000	1978	14
	Paris, ÃŽle-De-France, France	1001-5000	1996	21
	Paris, ÃŽle-De-France, France	201-500	1969	40
	Zurich, Zurich, Switzerland	10001+	1864	0
	Henley-In-Arden, England, United Kingdom (UK)	51-200	1982	41
	Antwerp, Flanders, Belgium	1001-5000	2001	5
	London, England, United Kingdom (UK)	201-500	1989	14

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical packagingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!